Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
09/13/20173:35PMGlobeNewswire Inc.Summit Therapeutics Announces Proposed Public Offering of $15.0 Million of American Depositary SharesNASDAQ:SMMTSummit Therapeutics Inc
09/11/20176:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/11/20176:00AMGlobeNewswire Inc.Summit Awarded BARDA Contract Worth Up to $62 Million to Support the Development of Ridinilazole for the Treatment of C. diff...NASDAQ:SMMTSummit Therapeutics Inc
09/05/20173:45PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/05/20176:00AMGlobeNewswire Inc.Summit Announces Positive Top-Line Data From an Exploratory Phase 2 Clinical Trial Supporting Ridinilazole as a Highly Select...NASDAQ:SMMTSummit Therapeutics Inc
08/31/20178:24AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
08/31/20176:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Second Quarter and Half Year Ended 31 July 2017 and Operational Progre...NASDAQ:SMMTSummit Therapeutics Inc
08/25/20178:30AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2017 on 31 August 2017NASDAQ:SMMTSummit Therapeutics Inc
08/03/20176:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
07/20/20176:30AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
07/18/20174:16PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/22/20174:44PMDow Jones NewsADRs End Higher; Pharmaceuticals Trade ActivelyNASDAQ:SMMTSummit Therapeutics Inc
06/22/201710:21AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
06/22/20176:00AMGlobeNewswire Inc.Summit Presents Data From Phase 1 Clinical Programme of Ezutromid at the European Paediatric Neurology Society CongressNASDAQ:SMMTSummit Therapeutics Inc
06/15/20176:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in JMP Securities Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
06/14/20173:16PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/14/20176:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2017 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
06/13/20176:00AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the First Quarter Ended 30 April 2017 on 14 June 2017NASDAQ:SMMTSummit Therapeutics Inc
06/05/20176:00AMGlobeNewswire Inc.Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017NASDAQ:SMMTSummit Therapeutics Inc
05/23/20176:00AMGlobeNewswire Inc.Summit Announces Key Appointments to Strengthen Research and Development TeamNASDAQ:SMMTSummit Therapeutics Inc
05/15/20177:38AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
05/15/20176:00AMGlobeNewswire Inc.Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDNASDAQ:SMMTSummit Therapeutics Inc
04/28/20175:30PMGlobeNewswire Inc.Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases With Data Showing Summit’s Ridinilazole Achieved Stati...NASDAQ:SMMTSummit Therapeutics Inc
04/27/201710:25AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
04/25/20173:12PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/13/20174:20PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
03/30/20176:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the Needham Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
03/29/20173:28PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
03/29/20176:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2017 and Operational Pr...NASDAQ:SMMTSummit Therapeutics Inc
03/28/20175:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT